{"id":"W2067725825","doi":"10.1016/j.bbmt.2014.12.028","title":"New Cancers after Autotransplantations for Multiple Myeloma","year":2014,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Terumo BCT; Genentech; Health Resources and Services Administration; Medac; Swedish Orphan Biovitrum; Otsuka America; Incyte; Allos Therapeutics; Ariad Pharmaceuticals; Actinium Pharmaceuticals; Blue Cross and Blue Shield Association; Kiadis Pharma; Therakos; Sigma-Tau Pharmaceuticals; Chimerix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Takeda Oncology; University of Minnesota; Amgen; Otsuka America Pharmaceutical; Teva Pharmaceutical Industries; HistoGenetics; WellPoint; U.S. Navy; Osiris Therapeutics; Celgene; Health Research; Onyx Pharmaceuticals; U.S. Department of Defense; Sanofi; Be The Match Foundation; GlaxoSmithKline","keywords":"Medicine; Incidence (geometry); Multiple myeloma; Cohort; Internal medicine; Confidence interval; Cumulative incidence; Population; Cancer; Relative risk; Oncology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003072561,0.0001740695,0.0002888495,0.0005688432,0.0003892443,0.0005708851,0.0002209183,0.0002648886,0.001148386],"category_scores_gemma":[0.001072692,0.0002125095,0.0004588001,0.0008850021,0.0001617255,0.0004286393,0.0004326319,0.0005840849,0.0001512801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004017795,"about_ca_system_score_gemma":0.0003208196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005421577,"about_ca_topic_score_gemma":0.00898303,"domain_scores_codex":[0.9996258,0.0000406065,0.00004331631,0.00009826826,0.0001178564,0.00007414516],"domain_scores_gemma":[0.9986672,0.0001776023,0.0007796099,0.00006141002,0.000101442,0.0002126996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004436994,0.00001343368,0.9973628,0.00001061673,0.00003147173,0.00009263236,0.00003057014,0.00004452602,0.00008646317,0.000007702314,0.0001271209,0.002148377],"study_design_scores_gemma":[0.000003169968,0.00003067082,0.9986713,0.000007829608,0.000021127,0.0006805242,0.00004093054,0.00009266345,0.0000633976,0.00001493567,0.0003707892,0.000002512946],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964413,0.001922493,0.000129495,0.00006186247,0.00001240847,0.000005687698,0.00089701,0.00001155036,0.0005181625],"genre_scores_gemma":[0.9980282,0.0007252777,0.00009194002,0.00003896659,0.00002779356,0.000006524396,0.0008598655,0.00000245555,0.0002189665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005421577,"threshold_uncertainty_score":0.01078004,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01415954141884324,"score_gpt":0.279854081265248,"score_spread":0.2656945398464048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}